Advertisement

CHEST Physician

Make CHEST Physician® a trusted source
  • Real-world data show adherence to nodal dissection standard improves detection of lymph node involvement in patients with NSCLC

    Real-world data show adherence to nodal dissection standard improves detection of lymph node involvement in patients with NSCLC

    Increased lymph node analysis was associated with a 2.1% absolute increase in pathologic nodal upstaging, according to recent research.


  • Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF

    Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF

    Researchers said the findings support evaluation of sleep‑related comorbidities to identify potentially modifiable contributors to symptoms and physiologic impairment.


  • Effects of LAMA or ICS withdrawal may increase risk for COPD exacerbations

    Effects of LAMA or ICS withdrawal may increase risk for COPD exacerbations

    Discontinuing LAMA or ICS treatment may more than double the risk of exacerbations for up to 90 days, according to an analysis by Alexander Mathioudakis, MD, PhD.



  • RSV hospitalization increases cardiorespiratory event, COPD exacerbation risk

    RSV hospitalization increases cardiorespiratory event, COPD exacerbation risk

    Caihua Liang, MD, PhD, and Elizabeth Begier, MD, discuss the importance of prevention in light of data showing elevated risk for up to 180 days following the acute infection.


  • Navigating AI’s emerging role in critical care

    Navigating AI’s emerging role in critical care

    AI tools like OpenEvidence are changing the way critical care clinicians learn, study, and practice medicine in the ICU setting.


  • Local and state options for clean air and climate advocacy

    Local and state options for clean air and climate advocacy

    Health care professionals can help drive practical, equitable clean air solutions that protect patients by leveraging their expertise in the clinic, community, and policy arena.


  • Airway clearance pharmacotherapy: Past, present, and future

    Airway clearance pharmacotherapy: Past, present, and future

    The central question in non-CF bronchiectasis is no longer whether mucoactives work but for whom, under what circumstances, and at what cost in treatment burden.


  • Interfaces for long-term noninvasive PAP in children

    Interfaces for long-term noninvasive PAP in children

    Noninvasive PAP supports respiratory function in children but depends on a well-fitting interface, such as a nasal mask, and monitoring to reduce adverse effects.



  • Biologic therapies in asthma: From foundation to the future

    Biologic therapies in asthma: From foundation to the future

    Biologic therapies are changing severe asthma management, shifting the goal from control to remission. Diego J. Maselli, MD, FCCP; Dharani Narendra, MD, FCCP; and Megan Conroy, MD, MAEd, FCCP, explore their impact in this installment of Clinical Outlook in Pulmonology.


  • Bilateral lung transplant comparable to heart-lung transplant in primary PAH

    Bilateral lung transplant comparable to heart-lung transplant in primary PAH

    Recent findings reinforce the widely used strategy of bilateral lung transplantation for most patients with primary PAH who do not have structural heart disease.